Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.
 
Researchers:
Have you heard a story, statistic, or discovery that might interest the public? Let us know about it!
 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

  

AHAF Research Grants

Tabbed Applet for Main Research Page
American Health Assistance Foundation (AHAF)

AHAF has awarded more than $115 million to fund
research for age-related diseases.*

Click on the tabs to learn more about funding opportunities
or apply for a grant as it pertains to Alzheimer's disease,
macular degeneration or glaucoma.

Since 1985, the Alzheimer's Disease Research (ADR) program the American Health Assistance Foundation (AHAF) has awarded more than $74.4 million to support promising research in fields ranging from molecular biology to epidemiology. ADR is currently supporting 61 outstanding biomedical research projects..

 
The Macular Degeneration Research Program (MDR) is the newest AHAF program. Since 1999, AHAF has awarded over $11.5 million to support basic research into the causes and potential treatments of this disease. MDR is currently supporting 34 biomedical research projects.

 
Since the National Glaucoma Research (NGR) program began in 1978, AHAF has awarded more than $20 million to support basic research into the causes and potential treatments of this disease. NGR is currently supporting 29 biomedical research projects.

 

 

 

Important Dates

Alzheimer's Disease Research

Standard Awards = $400,000 budgeted over 3 years
Pilot Awards = $150,000 budgeted over 2 years
Research Fellowships = $100,000 budgeted over 2 years

  • FY12 applications due October 12, 2011.

  • Please sign up for email notification of new RFP announcements and application deadlines by using the following link to our website: E-mail notification

Macular Degeneration Research ($100,000 budgeted over 2 years)

  • FY12 applications due November 9, 2011 by invitation only, following successful Letter of Intent submission.

  • Please sign up for email notification of new RFP announcements and application deadlines by using the following link to our website: E-mail notification

 

National Glaucoma Research ($100,000 budgeted over 2 years)

  • FY12 applications due October 26, 2011.

  • Please sign up for email notification of new RFP announcements and application deadlines by using the following link to our website: E-mail notification

 
Researcher Spotlight

Stanley Prusiner, M.D.
Stanley Prusiner, M.D., a neurobiologist at the University of California at San Francisco, was awarded the 1997 Nobel Prize in Medicine for his groundbreaking discovery and definition of a new class of disease-causing agents called prions. Dr. Prusiner's early research program was supported by AHAF. He now serves as an honorary member of the AHAF board of directors. Read more…
Apply for Grant Funding
Find out about current funding opportunities and how to apply for grants online. Find out more...
Research We Have Funded
Learn about the promising research we currently support and our previous research over the years.
For Current Awardees
Researchers, find all the necessary reporting forms and follow up information required after receiving a grant. Find out more...
Molecular Neurodegeneration: The Official Journal of AHAF
Molecular Neurodegeneration publishes peer-reviewed, original scientific research on the causes of neurodegenerative diseases, like Alzheimer's or Parkinson's, and on the pre-clinical testing of potential therapies for these devastating diseases. MN now ranks 30th among 237 neuroscience journals published worldwide with an impact score of 5.36.


Last Review: 09/23/11